IP Library Assignment 054245/0537
Patent Assignment
Reel/Frame 054245/0537

Change of Name

Recorded: 2020-10-28 Pages: 3
Assignor
BIOATLA, LLC
Executed: 2020-07-13
Assignee
BIOATLA, INC.
11085 TORREYANA ROAD, SUITE 100, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (40)
Novel Methods of Protein Evolution
Application: 17/039,510 →
Publication: US 2021/0017221
Mirac Proteins
Application: 15/699,543 →
Publication: US 2017/0369867
Express Humanization of Antibodies
Application: 16/749,643 →
Publication: US 2020/0157247
Comprehensive Monoclonal Antibody Generation
Application: 16/859,150 →
Publication: US 2020/0256875
Simultaneous, Integrated Selection and Evolution of Antibody/Protein Performance and Expression in Production Hosts
Application: 16/118,673 →
Publication: US 2018/0371452
Modified Antibody Regions and Uses Thereof
Application: 15/910,588 →
Publication: US 2018/0186863
Conditionally Active Biological Proteins
Application: 16/423,718 →
Publication: US 2019/0284551
Proteins Targeting Orthologs
Application: 15/759,739 →
Publication: US 2018/0259536
Discovering and Producing Conditionally Active Biologic Proteins in the Same Eukaryotic Cell Production Hosts
Application: 16/670,506 →
Publication: US 2020/0216834
Conditionally Active Chimeric Antigen Receptors for Modified T-Cells
Application: 15/504,470 →
Publication: US 2017/0260261
Conditionally Active Chimeric Antigen Receptors for Modified T-Cells
Application: 16/053,166 →
Publication: US 2018/0340021
Conditionally Active Chimeric Antigen Receptors for Modified T-Cells
Application: 16/125,302 →
Publication: US 2019/0010220
Conditionally Active Chimeric Antigen Receptors for Modified T-Cells
Application: 15/753,872 →
Publication: US 2019/0010219
Conditionally Active Biological Proteins
Application: 16/733,358 →
Publication: US 2020/0199578
Anti-Axl Antibodies, Antibody Fragments and Their Immunoconjugates and Uses Thereof
Application: 16/088,765 →
Publication: US 2019/0177417
Anti-ROR2 Antibodies, Antibody Fragments, Their Immunoconjucates and Uses Thereof
Application: 16/088,769 →
Publication: US 2020/0002414
Conditionally Active Polypeptides and Methods of Generating Them
Application: 16/324,453 →
Publication: US 2020/0190503
Conditionally Active Polypeptides
Application: 15/773,122 →
Publication: US 2020/0407439
Protein Therapeutics for Treatment of Senescent Cells
Application: 16/474,893 →
Publication: US 2021/0230221
Novel Methods of Protein Evolution
Application: 13/810,601 →
Publication: US 2013/0116125
Novel Methods of Protein Evolution
Application: 16/047,101 →
Publication: US 2018/0362576
Mirac Proteins
Patent: 9,637,735 →
Application: 14/464,059 →
Publication: US 2014/0356344
Mirac Proteins
Patent: 9,982,252 →
Application: 14/483,980 →
Publication: US 2014/0378660
Mirac Proteins
Patent: 9,464,284 →
Application: 13/255,676 →
Publication: US 2012/0164127
Mirac Proteins
Patent: 9,637,734 →
Application: 14/196,950 →
Publication: US 2014/0187748
Mirac Proteins
Patent: 8,709,755 →
Application: 13/523,509 →
Publication: US 2012/0258865
Mirac Proteins
Patent: 9,994,841 →
Application: 15/337,283 →
Publication: US 2017/0044522
Express Humanization of Antibodies
Application: 15/593,721 →
Publication: US 2017/0247473
Express Humanization of Antibodies
Patent: 9,683,054 →
Application: 13/977,166 →
Publication: US 2013/0303399
Comprehensive Monoclonal Antibody Generation
Application: 13/977,193 →
Publication: US 2013/0281303
Simultaneous, Integrated Selection and Evolution of Antibody/Protein Performance and Expression in Production Hosts
Application: 14/481,564 →
Publication: US 2015/0024944
Simultaneous, Integrated Selection and Evolution of Antibody/Protein Performance and Expression in Production Hosts
Patent: 8,859,467 →
Application: 13/384,362 →
Publication: US 2012/0165201
Simultaneous, Integrated Selection and Evolution of Antibody/Protein Performance and Expression in Production Hosts
Application: 13/298,559 →
Publication: US 2012/0245036
Multi-Specific Monoclonal Antibodies
Patent: 9,969,813 →
Application: 14/399,617 →
Publication: US 2015/0252119
Multi-Specific Monoclonal Antibodies
Application: 16/264,028 →
Publication: US 2019/0153120
Conditionally Active Biological Proteins
Application: 15/308,659 →
Publication: US 2017/0191055
Discovering and Producing Conditionally Active Biologic Proteins in the Same Eukaryotic Cell Production Hosts
Application: 15/329,491 →
Publication: US 2017/0247685
Conditionally Active Biological Proteins
Application: 15/546,883 →
Publication: US 2019/0024078
Anti-CD22 Antibodies
Patent: 9,856,323 →
Application: 14/396,869 →
Publication: US 2015/0086562
Diagnostics Using Conditionally Active Antibodies
Application: 15/404,060 →
Publication: US 2017/0199198
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 25, 2018
From: SHORT, JAY M.; CHANG, HWAI WEN; FREY, GERHARD
To: BIOATLA, LLC
Reel/Frame 046965/0667 →
Assignment of Assignor's Interest Nov 14, 2019
From: SHORT, JAY M.
To: BIOATLA, LLC
Reel/Frame 051010/0374 →
Change of Name Jun 13, 2023
From: BIOATLA, LLC
To: BIOATLA, INC.
Reel/Frame 063988/0603 →